ENTRY DATE: 2022
BUSINESS: Capital Risque
The company was founded in 2019 by David Del Bourgo, a former engineer at General Electric Healthcare, and Julien Cottineau, a geneticist who trained at the Institut Imagine. Together, they have developed simulation software for the design of gene therapies. These consist of introducing genetic material into cells to treat a disease.